Clinical significance of platelet to neutrophil ratio and platelet to lymphocyte ratio in patients with aneurysmal subarachnoid hemorrhage
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yun, Seonyong | - |
dc.contributor.author | Yi, Ho Jun | - |
dc.contributor.author | Lee, Dong Hoon | - |
dc.contributor.author | Sung, Jae Hoon | - |
dc.date.accessioned | 2022-06-09T04:43:01Z | - |
dc.date.available | 2022-06-09T04:43:01Z | - |
dc.date.issued | 2021-10 | - |
dc.identifier.issn | 0967-5868 | - |
dc.identifier.issn | 1532-2653 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/21017 | - |
dc.description.abstract | The aim of study was aimed to investigate associations of platelet-to-neutrophil ratio (PNR) and platelet to-lymphocyte ratio (PLR) on admission with clinical outcomes of patients with aneurysmal subarachnoid hemorrhage (aSAH). A retrospective analysis was performed on patients who were treated for aSAH. Unfavorable clinical outcome was defined as Modified Rankin Scale (mRS) score of 3-6 at 90 days. Receiver operating characteristic curve analysis was performed to detect optimal cutoff values of PNR and PLR for predicting clinical outcomes. Logistic regression was used to explore associations of PNR and PLR with clinical outcomes. A total of 544 patients with aSAH were enrolled. Of them, 152 (29.9%) had unfavorable clinical outcome. Optimal cutoff values of PNR and PLR to predict clinical outcomes at 90 days after aSAH were 25 and 130, respectively (P < 0.001 and <0.001, respectively). In multivariate logistic regression analysis, PNR <25 and PLR > 130 were associated with unfavorable clinical outcome at 90 days after aSAH (odds ratio [OR]: 1.81; 95% confidence interval [CI]: 1.23-3.69; P = 0.018 and OR: 1.56; 95% CI: 1.18-2.62; P = 0.031, respectively). PNR and PLR as novel inflammatory biomarkers could predict the clinical outcome after aSAH. PNR <22 and PLR > 130 were associated with unfavorable clinical outcome at 90 days after aSAH. (c) 2021 Elsevier Ltd. All rights reserved. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Churchill Livingstone | - |
dc.title | Clinical significance of platelet to neutrophil ratio and platelet to lymphocyte ratio in patients with aneurysmal subarachnoid hemorrhage | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1016/j.jocn.2021.07.036 | - |
dc.identifier.scopusid | 2-s2.0-85111826506 | - |
dc.identifier.wosid | 000697027600010 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Neuroscience, v.92, pp 49 - 54 | - |
dc.citation.title | Journal of Clinical Neuroscience | - |
dc.citation.volume | 92 | - |
dc.citation.startPage | 49 | - |
dc.citation.endPage | 54 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | DELAYED CEREBRAL-ISCHEMIA | - |
dc.subject.keywordPlus | STROKE PATIENTS | - |
dc.subject.keywordPlus | BRAIN-INJURY | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | VASOSPASM | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | PREDICTOR | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordAuthor | Aneurysm | - |
dc.subject.keywordAuthor | Leukocytes | - |
dc.subject.keywordAuthor | Lymphocytes | - |
dc.subject.keywordAuthor | Neutrophils | - |
dc.subject.keywordAuthor | Platelets | - |
dc.subject.keywordAuthor | Subarachnoid hemorrhage | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.